Notch1 and Sox2 have been shown to act in a negative feedback loop to suppress each other in triple-negative breast cancer, and Sox2+ tumours have enhanced CSC attributes compared to Notch1+ tumours [45]. The gene discussed is SOX2; the disease is triple-negative breast carcinoma.